Press Releases

18.03.2025

Results of the 2025 Annual General Meeting for the 2023/24 financial year of BRAIN Biotech AG

Corporate

Show Article

26.02.2025

3M FY 24/25: Starting the year with double digit sales growth in the core BRAINBiocatalysts division

Finance

Show Article

13.02.2025

Biological gold recycling: BRAIN Biotech AG collaborates with PX Group on the PX Urban Mining Initiative

Corporate Technology

Show Article

15.01.2025

Annual Report 2023/24: BRAIN Biotech AG acts from a strong cash position and is confident about its growth prospects

Finance

Show Article

12.12.2024

BRAIN Biotech AG sharpens focus on profitable growth

Corporate

Show Article

31.10.2024

BRAIN Biotech AG and Akribion Therapeutics GmbH sign exclusive pharma licensing agreement for G-dase® E CRISPR-Cas technology

Corporate

Show Article

08.10.2024

BRAIN Biotech and Biodiscovery: Strategic partnership expands access to untapped enzymes for industrial application via MetXtra™

Technology

Show Article

03.10.2024

Prof. Dr. Wiltrud Treffenfeldt leaves Supervisory Board of BRAIN Biotech AG for personal reasons

Corporate

Show Article

01.10.2024

BRAIN Biotech AG and Biocatalysts Ltd Launch a New Initiative to Revolutionize Enzyme Solutions within the Life Science Industry

Corporate

Show Article